Return to homepagePandemic Pact

Themis Bioscience GmbH

  • Funded by Austrian Research Promotion Agency (FFG)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Austrian Research Promotion Agency (FFG)

  • Research Location

    Austria

  • Lead Research Institution

    Themis Bioscience GmbH

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Development of a new vaccine against the coronavirus with a prophylactic agent. The plan is to start the first clinical studies (phase 1) in Austria and the USA in summer 2020.